Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Fehmi, Hindilerden"'
Autor:
Mehmet Baysal, Fehmi Hindilerden, Elif Gülsüm Umit, Ahmet Muzaffer Demir, Fatma Keklik Karadağ, Güray Saydam, Seval Akpınar, Burhan Turgut, Vildan Özkocaman, Fahir Özkalemkaş, Rafiye Çiftçiler, Can Özlü, Sinan Demircioğlu, Yıldız İpek, Reyhan Diz Küçükkaya
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 4, Pp 251-257 (2023)
Objective: In recent years, new developments have been incorporated into daily practice in the management of immune thrombotic thrombocytopenic purpura (iTTP). In particular, clinical scoring systems could help clinicians with clinical decision-makin
Externí odkaz:
https://doaj.org/article/e89a463303e642d4a3be2d616bf175e6
Autor:
Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy, Aynur Daglar Aday, Emine Gültürk, Meliha Nalçacı, İpek Yönal Hindilerden
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp 2-3 (2024)
Objective: Philadelphia chromosome-negative myeloproliferative neoplasms (Ph- MPNs) are characterized by clonal myeloproliferation and somatic mutations. Major complications of Ph-MPNs are thrombosis, bleeding, transformation to myelofibrosis and leu
Externí odkaz:
https://doaj.org/article/31af40f7c73d4937be3657f709e111a7
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 174-182 (2023)
Objective: The impact of JAK2V617F allele burden on clinical course in Philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) is not clear. We analyzed the clinical impact of JAK2V617F allele burden in a relatively large series of pa
Externí odkaz:
https://doaj.org/article/b3485c7898604b8e994962da9794d8d5
Autor:
Eren Arslan Davulcu, Tarık Onur Tiryaki, Elif Aksoy, Emine Gültürk, İpek Yönal Hindilerden, Meliha Nalçacı, Fehmi Hindilerden
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S39-S40 (2023)
Objective: Autoimmune hemolytic anemias (AIHA) are rare disorders where autoantibodies destroy self-red blood cells. AIHA includes warm AIHA (wAIHA), cold AIHA (cAIHA or cold agglutinin disease), mixed AIHA (mAIHA), paroxysmal cold hemoglobinuria (PC
Externí odkaz:
https://doaj.org/article/0edee5796bdc4344843d84c23bd75bdf
Autor:
Fehmi Hindilerden, Ipek Yonal-Hindilerden, Mustafa Nuri Yenerel, Meliha Nalcaci, Reyhan Diz-Kucukkaya
Publikováno v:
Hematology Reports, Vol 14, Iss 3, Pp 222-227 (2022)
No data exist for the association between the presence of accessory spleen after splenectomy and response to rituximab in immune thrombocytopenia (ITP). We investigated the relationship between accessory spleen presence and rituximab response in sple
Externí odkaz:
https://doaj.org/article/68343ad2459a4a9a8115e3b707839d6d
Autor:
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Mustafa Baydar, Lale Aydın Kaynar, Selami Koçak Toprak, Hasan Sami Göksoy, Berrin Balık Aydın, Ufuk Demirci, Ferda Can, Vildan Özkocaman, Eren Gündüz, Zeynep Tuğba Güven, Zübeyde Nur Özkurt, Sinan Demircioğlu, Meral Beksaç, İdris İnce, Umut Yılmaz, Hilal Eroğlu Küçükdiler, Elgün Abishov, Boran Yavuz, Ünal Ataş, Yaşa Gül Mutlu, Volkan Baş, Fahir Özkalemkaş, Hava Üsküdar Teke, Vildan Gürsoy, Serhat Çelik, Rafiye Çiftçiler, Münci Yağcı, Pervin Topçuoğlu, Özcan Çeneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yücel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Güler, Muzaffer Keklik, Hatice Terzi, Ali Doğan, Zeynep Arzu Yegin, Meltem Kurt Yüksel, Soğol Sadri, İrfan Yavaşoğlu, Hüseyin Saffet Beköz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagül Kaynar, Osman İlhan, Ali Zahit Bolaman, Ömür Gökmen Sevindik, Arzu Akyay, Muhit Özcan, Günhan Gürman, Şule Ünal, Yasemin Yavuz, Reyhan Diz Küçükkaya, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 43-54 (2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as
Externí odkaz:
https://doaj.org/article/ef03a300a9a44beba39b3be598d50f71
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 44, Iss , Pp S31- (2022)
Introduction: Rituximab-induced lung disease (R-ILD) is a rare entity that should be considered in patients treated with rituximab who present with dyspnea, fever, and cough but no clear evidence of infection. We describe the clinical presentation, m
Externí odkaz:
https://doaj.org/article/d50e30c2071e4864956271835fe9d37e
Autor:
Sevil SADRİ, İpek YÖNAL HİNDİLERDEN, Yaşa Gül MUTLU, Tarık Onur TİRYAKİ, Ali İhsan GEMİCİ, Huseyin Saffet BEKOZ, Ömür GÖKMEN SEVİNDİK, Fehmi HİNDİLERDEN, Sevgi KALAYOĞLU-BEŞIŞIK, Meliha NALÇACI, Deniz SARGIN
Publikováno v:
The European Research Journal. :1-12
Objectives: The main objective of the present study was to evaluate whether the use of plerixafor in combination with granulocyte colony-stimulating factor (G-CSF) or subsequent use of isolated G-CSF and then plerixafor following disease-specific che
Autor:
Ipek Yonal-Hindilerden, Fehmi Hindilerden, Metban Mastanzade, Tarik Onur Tiryaki, Sevim Tasan-Yenigun, Yusuf Bilen, Selcuk Aksoz, Arif Atahan Cagatay, Meliha Nalcaci
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
First identified in China in December 2019, coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. The presence of haematological malignancies are expected to increase the risk of adverse outcomes from this viral infection du
Externí odkaz:
https://doaj.org/article/565fc52f722e4c2d89f91a71482bd096
Autor:
Fatih Akboğa, Fehmi Hindilerden, Emine Gültürk, İpek Yönal Hindilerden, Abdullah Yılmaz, Günnur Deniz, Metin Gelmez
Publikováno v:
Experimed. 12:225-231